LESLIE TARLOW: Open Payments
NPI 1528282852 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,603 in 45 payments from 5 companies in 2025. Trend: 2023 $7,088 · 2024 $3,219 · 2025 $18,603
Speaker / faculty: $12,898Travel & lodging: $3,024Food & beverage: $1,485Consulting: $1,140Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $8,714 |
| TG Therapeutics, Inc. | 25 | $8,243 |
| EMD Serono, Inc. | 6 | $1,515 |
| Biogen, Inc. | 2 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
Products named: BRIUMVI, Mavenclad, KESIMPTA, TYSABRI, VUMERITY.
Industry payments across CA — which companies pay providers there.
